Randomized trial · people

DSIP gave only weak sleep gains in 16 people with chronic insomnia

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In this small human trial, a few doses of DSIP brought only weak changes in measured sleep and no change in how well people felt they slept.

Kind
Randomized trial
Studied in
People
Number studied
16
Published
1992
Journal
Neuropsychobiology

What they tested

The team tested whether DSIP improves sleep in people with long-term insomnia.

How the study was done

A double-blind, randomized, placebo-controlled trial in 16 patients with chronic insomnia, arranged as matched pairs split into two parallel groups. Each person spent 5 nights in a sleep lab. Night 1 was for getting used to the lab and night 2 was a baseline. Before nights 3, 4 and 5, half got an intravenous (into a vein) dose of 25 nmol/kg DSIP in the afternoon and half got a glucose solution as placebo, a dummy treatment.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking DSIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

On polysomnography, an overnight recording of brain waves and body signals, the DSIP group had higher sleep efficiency (the share of time in bed spent asleep) and fell asleep faster than the placebo group. One measure of how tired people felt went down in the DSIP group. These statistically significant effects were weak, and part of the gap may have come from a chance change in the placebo group. No other measure changed, including how well people felt they slept, and the team concluded that short-term DSIP is unlikely to offer major benefit for chronic insomnia.

What it doesn’t show

The trial was small, with 16 people, and short, with only 3 doses over 3 nights. It does not show what longer use would do.

The paper

Bes et al. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology. 1992.

The compound

More studies on DSIP

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking DSIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo